Latest filing published 27 Aug 2018 for Bionano Genomics, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Domain Partners VIII, L.P. across 4 companies, led by Bionano Genomics, Inc., Dicerna Pharmaceuticals Inc and Ocera Therapeutics, Inc. Between 8 March 2016 and 23 August 2018, the trades on record add up to 7 filings.
On the market, this insider has only ever bought: 1 purchase, €80k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. So far in 2018, the count stands at 1 purchase and no sales.
On 27 August 2018 came the latest disclosure, a transaction in Bionano Genomics, Inc. The latest purchase dates back some time: it was published 2,979 days ago, on 27 August 2018. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations